---
title: "\"Performance\" LUXXU GROUP's annual loss narrowed to 21.687 million RMB"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281106838.md"
description: "LUXXU GROUP announced its performance for the fiscal year 2025, with revenue of 42.07 million yuan (same below), an increase of 43.2% year-on-year. Losses narrowed to 21.687 million yuan, compared to a loss of 51.964 million yuan in the same period last year; loss per share was 12.19 cents. No dividend was declared"
datetime: "2026-03-31T01:40:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281106838.md)
  - [en](https://longbridge.com/en/news/281106838.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281106838.md)
---

# "Performance" LUXXU GROUP's annual loss narrowed to 21.687 million RMB

LUXXU GROUP (01327.HK) announced its 2025 annual results, with revenue of RMB 42.07 million, an increase of 43.2% year-on-year. Losses narrowed to RMB 21.687 million, compared to a loss of RMB 51.964 million in the same period last year; loss per share was 12.19 cents. No dividend was declared

### Related Stocks

- [01327.HK](https://longbridge.com/en/quote/01327.HK.md)

## Related News & Research

- [Luxxu Group Raises HK$20.8 Million Through Share Placing to Reduce Debt](https://longbridge.com/en/news/290821652.md)
- [Wall Street Hasn’t Discovered This Winning Stock. That Means Now Could Be a Good Time to Buy.](https://longbridge.com/en/news/290716701.md)
- [Valuation Reboot: Tracking the Tectonic Shifts Across 82 Key HK & US Equities](https://longbridge.com/en/news/290538509.md)
- [Fosun Pharma unit Fosun Adgenvax files for Hong Kong IPO in proposed spin-off listing](https://longbridge.com/en/news/290957351.md)
- [CITIC Resources says unaware of reasons behind unusual share moves, flags 10.01% stake sale by Chan Kin vehicle](https://longbridge.com/en/news/290978997.md)